By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Syrian Arab News Agency (SANA)
  • Latest News
  • Syria
  • Middle East
  • Economy
  • Politics
  • Sport
  • International
Reading: First clinical trial begins for experimental immunotherapy targeting solid tumors
  • AR
  • TR
  • FR
  • ES
  • KU
  • Culture
  • Video
  • Photos
  • Miscellaneous
Syrian Arab News Agency (SANA)Syrian Arab News Agency (SANA)
  • Latest News
  • Syria
  • Middle East
  • Economy
  • Politics
  • Sport
  • International
Search
  • Latest News
  • News Categories
    • Politics
    • Culture
    • Video
    • Photos
    • Miscellaneous
  • Provinces
  •  Languages
    • العربية
    • Türkçe
    • Français
    • Español
    • Kurdî
Follow US
Syrian Arab News Agency (SANA) > Latest News > Miscellaneous > First clinical trial begins for experimental immunotherapy targeting solid tumors

First clinical trial begins for experimental immunotherapy targeting solid tumors

Published: 2026/08/03 1:58 PM
Updated: 2026/08/03 1:58 PM
First clinical trial begins for experimental immunotherapy targeting solid tumors
First clinical trial for experimental immunotherapy, solid tumors

London, Aug. 3 (SANA) The world’s first clinical trial of an experimental immunotherapy known as ZI-MA4-1 has begun after a British patient with advanced ovarian cancer received the treatment’s first dose, marking a step toward evaluating a potential new therapy for a range of solid tumors.

According to The Sun, 58-year-old Tracy Tomlinson became the first patient to receive the investigational treatment at The Christie in Manchester. The trial, conducted in collaboration with The Royal Marsden Hospital in London, includes patients with ovarian, lung, soft tissue sarcoma and head and neck cancers.

The therapy combines natural killer (NK) cells with genetically engineered T-cell receptors (TCRs). The modified immune cells are designed to recognize and target the MAGE-A4 protein, which is expressed in several types of cancer cells.

Unlike personalized cell therapies that must be manufactured individually for each patient, ZI-MA4-1 is designed as an off-the-shelf therapy derived from donor immune cells, potentially making it available to a larger number of patients.

Tomlinson was diagnosed with ovarian cancer in 2020 and underwent surgery and chemotherapy before the disease returned, making her eligible for the trial. The initial phase is focused on assessing the treatment’s safety before researchers evaluate its effectiveness in controlling tumor growth and improving patient outcomes.

Researchers said that, if successful, the approach could broaden access to immunotherapy and provide a new treatment option for patients with advanced solid tumors that are difficult to treat using conventional therapies.

R.H/Abd

China Unveils New AI Model to Revolutionize Agriculture
WhatsApp users can now save favorite songs for Status posts
Damascus producers keep Syria’s centuries-old Qamar al-Din tradition alive
IACA launches Global Passport to enhance connectivity in Int’l dispute resolution
U.S. cancer study in Washington links glucose to immune evasion mechanism
  • press
  • Photos
  • Video
  • Miscellaneous
TAGGED:Cancer ResearchClinical TrialImmunotherapy
Share This Article
Facebook Whatsapp Whatsapp LinkedIn Telegram Copy Link

Editors Choice

Syrian students conclude Italy visit aimed at strengthening educational ties

Syrian students conclude Italy visit aimed at strengthening educational ties

November 16, 2026
Xi, Trump and Putin set for first trilateral summit

Xi, Trump and Putin set for first trilateral summit

November 16, 2026
Syria clears wartime barriers across 841 kilometers of Aleppo countryside

Syria clears wartime barriers across 841 kilometers of Aleppo countryside

November 16, 2026
US Embassy in Bahrain warns of potential attacks on American interests

US Embassy in Bahrain warns of potential attacks on American interests

November 16, 2026
Syrian Arab News Agency (SANA)

Syrian Arab News Agency – SANA

The official national news agency of Syria, established on June 24, 1965. It is affiliated with the Ministry of Information and headquartered in Damascus.

  • Presidency
  • Politics
  • Syria
  • Economy
  • Health
  • International
  • Education
  • Culture
  • Sport
  • Tour Syria
  • press
  • Photos
  • Video
  • Miscellaneous
© Syrian Arab News Agency. All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?